Drug Profile
Malaria vaccine - rEVO Biologics
Alternative Names: MSP1-malaria vaccineLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator GTC Biotherapeutics
- Class Antimalarials; Parasitic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Malaria
Most Recent Events
- 04 Jan 2013 GTC Biotherapeutics is now called rEVO Biologics
- 11 Dec 2007 Preclinical development is ongoing
- 20 Jul 2005 This compound is still in active development - (BIO-2005)